Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Progyny Sees Q3 Sales $290.000M-$305.000M vs $290.721M Est

Author: Benzinga Newsdesk | August 07, 2025 04:05pm

Progyny (NASDAQ:PGNY) sees Q3 sales of $290.000 million-$305.000 million vs $290.721 million analyst estimate.

Posted In: PGNY